March 12, 2020
This morning, digital cardiology platform Heartbeat Health scored $8.2 million in Series A funding. Boston-based venture firm .406 Ventures and Optum Ventures led the round with participation from Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures.
WHAT THEY DO
The company is focused on using digital tools to aggregate heart data and provide care management to patients.
February 7, 2020
The first artificial intelligence-enabled cardiac ultrasound software has received De Novo marketing authorization, the FDA announced today. Developed by Caption Health, the Caption Guidance tool guides medical professionals through a heart disease diagnostic test that normally requires an ultrasound expert.
“Echocardiograms are one of the most widely-used diagnostic tools in the diagnosis and...
January 28, 2020
This morning digital cardiac health startup Eko announced that its atrial fibrillation and heart murmur detection algorithm landed a 510(k) FDA clearance. The new algorithms are designed to integrate with Eko’s stethoscope, which is already on the market, and be used by healthcare providers.
The company said it plans to add more algorithms in the future. Next up will be an ECG-based algorithm...
November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes.
So of course it’s little surprise that cardiovascular health and care...
June 27, 2019
Cardiogram, maker of a smartwatch app that uses deep neural network technology to detect various heart conditions, has inked a deal with Fitbit allowing its application to be integrated with the tech giant’s wearables.
As part of the integration Fitbit users can now download the Cardiogram app and use it to monitor heart rate and sleep tracking. Users will also have access to Cardiogram’s...
May 13, 2019
Mobile consumer ECG maker AliveCor announced today that its long-teased six-lead ECG device has been cleared by the FDA and will be available to customers in June of this year.
“[The KardiaMobile 6L clearance] is a big deal for us, and it’s important for patients and physicians because they will be able to get a materially improved view into patients’ hearts,” Dr. Jacqueline Shreibati, chief...
May 7, 2019
The FDA has cleared eMurmur ID, a software screening device that uses a smartphone, third-party digital stethoscope and machine learning to automate the detection of heart murmurs.
According to Ottawa, Canada-based eMurmur, the cloud tool identifies and classifies both dangerous and healthy heart murmurs, as well as the absence of a murmur and S1 or S2 heart sounds. The platform includes a mobile...
January 7, 2019
According to a new study published this morning in Nature, an algorithm trained via a deep neural network has been able to perform on par with board-certified cardiologists at the annotation of 12 different types of heart rhythms.
Researchers from Stanford University and iRhythm collaborated for the study, which detailed an algorithm trained on 91,232 30-second single-lead ECG readings from 53,...
September 10, 2018
A recent study published by JAMA Network Open found that follow-up home blood pressure telemonitoring could help patients with uncontrolled hypertension lower their blood pressure in the short term. However researchers found that in the long term, those who received the intervention had similar results to those who got the standard of care.
In the study, researcher analyzed blood pressure...
February 1, 2017
Pasadena, California-based Geneva Health Solutions, which makes a remote monitoring platform for cardiology practitioners, has raised $1.9 million in Series A funding in a round led by Nebraska Medicine, an early adopter of the cloud-based platform that aggregates data from a patient’s implanted cardiac device to their provider.
The funding will be used to carry the company through the next year...